Meeder Advisory Services’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $529K | Buy |
4,209
+2,599
| +161% | +$326K | 0.03% | 364 |
|
|
2025
Q1 | $220K | Buy |
1,610
+218
| +16% | +$29.8K | 0.01% | 526 |
|
|
2024
Q4 | $213K | Sell |
1,392
-130
| -9% | -$19.9K | 0.01% | 526 |
|
|
2024
Q3 | $295K | Sell |
1,522
-429
| -22% | -$83.2K | 0.02% | 441 |
|
|
2024
Q2 | $452K | Buy |
1,951
+422
| +28% | +$97.8K | 0.03% | 339 |
|
|
2024
Q1 | $330K | Sell |
1,529
-159
| -9% | -$34.3K | 0.03% | 337 |
|
|
2023
Q4 | $437K | Sell |
1,688
-6
| -0.4% | -$1.55K | 0.05% | 287 |
|
|
2023
Q3 | $435K | Sell |
1,694
-417
| -20% | -$107K | 0.05% | 284 |
|
|
2023
Q2 | $601K | Buy |
2,111
+126
| +6% | +$35.9K | 0.06% | 254 |
|
|
2023
Q1 | $552K | Buy |
1,985
+287
| +17% | +$79.8K | 0.06% | 259 |
|
|
2022
Q4 | $470K | Buy |
+1,698
| New | +$470K | 0.06% | 271 |
|